FI119572B - Menetelmä vatsan limakalvon tilan ennustamiseksi - Google Patents

Menetelmä vatsan limakalvon tilan ennustamiseksi Download PDF

Info

Publication number
FI119572B
FI119572B FI20040359A FI20040359A FI119572B FI 119572 B FI119572 B FI 119572B FI 20040359 A FI20040359 A FI 20040359A FI 20040359 A FI20040359 A FI 20040359A FI 119572 B FI119572 B FI 119572B
Authority
FI
Finland
Prior art keywords
data
mucosa
marker
database
class
Prior art date
Application number
FI20040359A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI20040359A0 (fi
FI20040359A (fi
Inventor
Osmo Suovaniemi
Tapani Tiusanen
Seppo Sarna
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Publication of FI20040359A0 publication Critical patent/FI20040359A0/fi
Priority to FI20040359A priority Critical patent/FI119572B/fi
Priority to ES05717315T priority patent/ES2325170T3/es
Priority to CNA2005800142478A priority patent/CN1950704A/zh
Priority to AT05717315T priority patent/ATE430938T1/de
Priority to JP2007501300A priority patent/JP4814212B2/ja
Priority to US10/598,606 priority patent/US20080162101A1/en
Priority to PL05717315T priority patent/PL1725876T3/pl
Priority to DE602005014345T priority patent/DE602005014345D1/de
Priority to PCT/FI2005/050061 priority patent/WO2005085871A1/en
Priority to EP05717315A priority patent/EP1725876B1/de
Publication of FI20040359A publication Critical patent/FI20040359A/fi
Application granted granted Critical
Publication of FI119572B publication Critical patent/FI119572B/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/595—Gastrins; Cholecystokinins [CCK]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)
    • G01N2333/96475—Aspartic endopeptidases (3.4.23) with definite EC number
    • G01N2333/96477—Pepsin (3.4.23.1; 3.4.23.2; 3.4.23.3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/062—Gastritis or peptic ulcer disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
FI20040359A 2004-03-05 2004-03-05 Menetelmä vatsan limakalvon tilan ennustamiseksi FI119572B (fi)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FI20040359A FI119572B (fi) 2004-03-05 2004-03-05 Menetelmä vatsan limakalvon tilan ennustamiseksi
JP2007501300A JP4814212B2 (ja) 2004-03-05 2005-03-03 胃粘膜の状態を予測するための方法
CNA2005800142478A CN1950704A (zh) 2004-03-05 2005-03-03 一种预测胃粘膜状态的方法
AT05717315T ATE430938T1 (de) 2004-03-05 2005-03-03 Verfahren zur vorhersage des zustands der magenschleimhaut
ES05717315T ES2325170T3 (es) 2004-03-05 2005-03-03 Un metodo para predecir el estado de la mucosa gastrica.
US10/598,606 US20080162101A1 (en) 2004-03-05 2005-03-03 Method for Predicting the State of the Gastric Mucosa
PL05717315T PL1725876T3 (pl) 2004-03-05 2005-03-03 Sposób przewidywania stanu śluzówki żołądka
DE602005014345T DE602005014345D1 (de) 2004-03-05 2005-03-03 Leimhaut
PCT/FI2005/050061 WO2005085871A1 (en) 2004-03-05 2005-03-03 A method for predicting the state of the gastric mucosa
EP05717315A EP1725876B1 (de) 2004-03-05 2005-03-03 Verfahren zur vorhersage des zustands der magenschleimhaut

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20040359 2004-03-05
FI20040359A FI119572B (fi) 2004-03-05 2004-03-05 Menetelmä vatsan limakalvon tilan ennustamiseksi

Publications (3)

Publication Number Publication Date
FI20040359A0 FI20040359A0 (fi) 2004-03-05
FI20040359A FI20040359A (fi) 2005-09-06
FI119572B true FI119572B (fi) 2008-12-31

Family

ID=32039385

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20040359A FI119572B (fi) 2004-03-05 2004-03-05 Menetelmä vatsan limakalvon tilan ennustamiseksi

Country Status (10)

Country Link
US (1) US20080162101A1 (de)
EP (1) EP1725876B1 (de)
JP (1) JP4814212B2 (de)
CN (1) CN1950704A (de)
AT (1) ATE430938T1 (de)
DE (1) DE602005014345D1 (de)
ES (1) ES2325170T3 (de)
FI (1) FI119572B (de)
PL (1) PL1725876T3 (de)
WO (1) WO2005085871A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011501177A (ja) * 2007-10-26 2011-01-06 ビオヒット・ユルキネン・オサケユキテュア 自己免疫疾患および萎縮性胃炎と関連する胃癌を診断するための方法および製品
WO2011161301A1 (en) * 2010-06-24 2011-12-29 Valtion Teknillinen Tutkimuskeskus State inference in a heterogeneous system
JP2014517279A (ja) 2011-05-10 2014-07-17 ネステク ソシエテ アノニム 個別治療管理のための疾患活動性プロファイリングの方法
AU2018277256A1 (en) 2017-05-31 2020-01-30 Prometheus Biosciences, Inc. Methods for assessing mucosal healing in Crohn's disease patients
CN112002414B (zh) * 2020-08-23 2024-01-26 吾征智能技术(北京)有限公司 一种基于胃液认知胃病的系统、设备、存储介质
CN113466471B (zh) * 2021-09-06 2021-11-26 中国农业科学院农产品加工研究所 胃粘膜损伤相关生物标志物、筛选方法及用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0746111B2 (ja) * 1988-03-18 1995-05-17 株式会社日立製作所 試料分析方法及びこれを用いた自動分析装置
US6861510B1 (en) * 1989-01-24 2005-03-01 Aphton Corporation Immunogenic compositions against gastrin peptides
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
JP2949474B2 (ja) * 1995-08-28 1999-09-13 隆久 古田 ペプシノーゲンｉ／ｉｉ比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法
JP2000270897A (ja) * 1999-03-23 2000-10-03 Mitsubishi Kagaku Bio-Clinical Laboratories Inc トランスフォーミング増殖因子β１の遺伝子多型による骨粗鬆症危険因子の検出法
FI118653B (fi) * 1999-04-30 2008-01-31 Biohit Oyj Menetelmä peptisen haavan riskin määrittämiseksi
WO2001077685A2 (en) * 2000-04-10 2001-10-18 The General Hospital Corporation Diagnosis and treatment of gastrointestinal disease
FI20010019A (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
FI20011908A (fi) * 2001-09-28 2003-03-29 Biohit Oyj Menetelmä vatsasyövän osoittamiseksi
SE0200974D0 (sv) * 2002-03-27 2002-03-27 Phagen Ab Screening method for gastritis
FI119571B (fi) * 2002-09-06 2008-12-31 Biohit Oyj Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
US6950544B2 (en) * 2003-02-14 2005-09-27 Virtualscopics, Llc Automated measurement of anatomical structures in medical imaging

Also Published As

Publication number Publication date
ATE430938T1 (de) 2009-05-15
PL1725876T3 (pl) 2009-10-30
CN1950704A (zh) 2007-04-18
WO2005085871A1 (en) 2005-09-15
ES2325170T3 (es) 2009-08-27
FI20040359A0 (fi) 2004-03-05
JP4814212B2 (ja) 2011-11-16
EP1725876B1 (de) 2009-05-06
JP2007526470A (ja) 2007-09-13
DE602005014345D1 (de) 2009-06-18
EP1725876A1 (de) 2006-11-29
FI20040359A (fi) 2005-09-06
US20080162101A1 (en) 2008-07-03

Similar Documents

Publication Publication Date Title
US7358062B2 (en) Method for diagnosing atrophic gastritis
Yu et al. Comparison of the Kato-Katz technique, hatching test and indirect hemagglutination assay (IHA) for the diagnosis of Schistosoma japonicum infection in China
Inoue et al. Prediction of prognosis of primary biliary cirrhosis in Japan
Shi et al. Insulin-like growth factor-I and prostate cancer: a meta-analysis
Anastasios et al. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings
Barreto et al. Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem
Thunander et al. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden
Vohlonen et al. Risk of gastric cancer in Helicobacter pylori infection in a 15-year follow-up
Riva et al. Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis
Moran et al. Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the multi-ethnic study of atherosclerosis (MESA)
Cheng et al. Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan
CN100573152C (zh) 评估患消化性溃疡的危险度的方法,包括定量测定血清样品中胃蛋白酶原i(pgi)和胃泌素-17的浓度的步骤
Rowlands et al. The relation between adiposity throughout the life course and variation in IGFs and IGFBPs: evidence from the ProtecT (Prostate testing for cancer and Treatment) study
Johnston et al. Preliminary results from follow‐up of a large‐scale population survey of antibodies to gliadin, reticulin and endomysium
EP1725876B1 (de) Verfahren zur vorhersage des zustands der magenschleimhaut
Lahner et al. Atrophic gastritis and pre-malignant gastric lesions
Joshi et al. Insulin-like growth factor-1, IGF-binding protein-3, C-peptide and colorectal cancer: a case-control study
Kamis et al. Neutrophil gelatinase-associated lipocalin levels during the first 48 hours of intensive care may indicate upcoming acute kidney injury
Mulshine et al. Molecular markers in early cancer detection: new screening tools
WO2018062743A1 (ko) 질 내 미생물을 포함하는 조성물
Sibai et al. Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery
Noah et al. Assessing GastroPanel serum markers as a non-invasive method for the diagnosis of atrophic gastritis and Helicobacter pylori infection
CN117169320A (zh) 一组用于结直肠癌诊断的血液多金属离子组合及其应用
Reichel et al. Evaluation of serum β-carboxy-terminal cross-linking telopeptide of type i collagen as marker of bone resorption in chronic hemodialysis patients
Nakamura et al. Age-related decrease in serum 25-hydroxyvitamin D concentrations in the frail elderly: a longitudinal study